Project Start
1982-09-01
Project End
1992-08-30
Budget Start
1988-09-01
Budget End
1989-08-31
Support Year
7
Fiscal Year
1988
Total Cost
Indirect Cost
Name
Johns Hopkins University
Department
Type
Schools of Medicine
DUNS #
045911138
City
Baltimore
State
MD
Country
United States
Zip Code
21218
Patel, Chirag H; Powell, Jonathan D (2017) Targeting T cell metabolism to regulate T cell activation, differentiation and function in disease. Curr Opin Immunol 46:82-88
Hallowell, R W; Collins, S L; Craig, J M et al. (2017) mTORC2 signalling regulates M2 macrophage differentiation in response to helminth infection and adaptive thermogenesis. Nat Commun 8:14208
Kwaa, Abena K; Goldsborough, Kennedy; Walker-Sperling, Victoria E et al. (2017) The effect of Ingenol-B on the suppressive capacity of elite suppressor HIV-specific CD8+ T cells. PLoS One 12:e0174516
Bailey, Justin R; Flyak, Andrew I; Cohen, Valerie J et al. (2017) Broadly neutralizing antibodies with few somatic mutations and hepatitis C virus clearance. JCI Insight 2:
Bettencourt, Ian A; Powell, Jonathan D (2017) Targeting Metabolism as a Novel Therapeutic Approach to Autoimmunity, Inflammation, and Transplantation. J Immunol 198:999-1005
Kates, Max; Nirschl, Thomas; Sopko, Nikolai A et al. (2017) Intravesical BCG Induces CD4+ T-Cell Expansion in an Immune Competent Model of Bladder Cancer. Cancer Immunol Res 5:594-603
Thiele Orberg, E; Fan, H; Tam, A J et al. (2017) The myeloid immune signature of enterotoxigenic Bacteroides fragilis-induced murine colon tumorigenesis. Mucosal Immunol 10:421-433
Pohlmyer, Christopher W; Bullen, C Korin; Martin, Alyssa R et al. (2017) Characterization of Elite Suppressors Cell-Associated HIV-1 mRNA at Baseline and with T Cell Activation??. Yale J Biol Med 90:331-336
Kosmides, Alyssa K; Sidhom, John-William; Fraser, Andrew et al. (2017) Dual Targeting Nanoparticle Stimulates the Immune System To Inhibit Tumor Growth. ACS Nano 11:5417-5429
El-Diwany, Ramy; Cohen, Valerie J; Mankowski, Madeleine C et al. (2017) Extra-epitopic hepatitis C virus polymorphisms confer resistance to broadly neutralizing antibodies by modulating binding to scavenger receptor B1. PLoS Pathog 13:e1006235

Showing the most recent 10 out of 182 publications